Approval · Notice of Compliance 20909 · 2018
AG-EZETIMIBE: Notice of Compliance 20909
Issued May 29, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20909
- Date
- May 29, 2018
- Company
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Canadian reference product
- EZETROL (Merck Frosst)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AG-EZETIMIBE | 02475898 | Marketed |
Medicinal ingredients
- EZETIMIBE 10 MG per TAB